Prevention of portal hypertension by propanolol and spironolactone in rats with bile duct ligation
- 31 January 1997
- journal article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 26 (1), 167-173
- https://doi.org/10.1016/s0168-8278(97)80023-2
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Effects of low-sodium diet and spironolactone on portal pressure in patients with compensated cirrhosisHepatology, 1994
- Serum hyaluronate reflects hepatic sinusoidal capillarizationGastroenterology, 1993
- Spironolactone (Sp) decreases portal pressure in patients with compensated cirrhosisJournal of Hepatology, 1991
- Early chronic administration of propranolol reduces the severity of portal hypertension and portal-systemic shunts in conscious portal vein stenosed ratsJournal of Hepatology, 1991
- Propranolol ameliorates the development of portal-systemic shunting in a chronic murine schistosomiasis model of portal hypertension.JCI Insight, 1991
- Propranolol decreases portal pressure without changing portocollateral resistance in cirrhotic ratsHepatology, 1989
- Reduction of intrahepatic vascular space in the pathogenesis of portal hypertensionGastroenterology, 1987
- Effect of propranolol on hepatic and systemic hemodynamics in dogs with chronic bile duct ligationHepatology, 1986
- Chronic Bile Duct Ligation in the Dog: Hemodynamic Characterization of a Portal Hypertensive ModelHepatology, 1983
- Portal Hypertension After Bile Duct ObstructionArchives of Surgery, 1979